Meridian’s Novel Air-Dryable qPCR Mix Decreases Costs and Simplifies Workflows for Molecular Test Manufacturers
February 26 2020 - 8:00AM
Meridian Bioscience, Inc. (NASDAQ: VIVO), following the extremely
successful launch of the Lyo-Ready qPCR mixes, is proud to
introduce today its Air-Dryable qPCR Mix. This specialized master
mix offers a cost-effective and easier alternative to freeze-drying
for ambient temperature stable real-time PCR assays.
Meridian’s Air-Dryable qPCR Mix has been
designed to simplify assay development and workflow through a
magnesium containing formulation allowing air or oven drying
protocols. Incorporation of the Air-Dryable qPCR mix in MDx assays
allows dry down and test stability at ambient temperature, removing
the need for cold chain shipping and storage. The Meridian
Air-Dryable qPCR Mix shows exceptionally high performance in
multiplex reactions following rehydration, making it ideally suited
for automated high-throughput platforms.
Molecular diagnostic tests are progressively
moving towards a dried down format; however, there are technical
challenges in developing lyophilization-compatible mixes that
require expensive lyophilization equipment. Building on its
expertise in ready-to-use, lyophilization-compatible products, the
Life Science division of Meridian Bioscience has successfully
developed a ready-to-use, air-dryable mix to suit a growing demand
within the molecular diagnostics industry for less complicated and
cost-effective method of drying their assays.
Lourdes Weltzien, PhD, Executive Vice President,
commented, “We are proud to announce the release of our new
Air-Dryable qPCR Mix. We now have an alternative to our Lyo-Ready
qPCR products that is ideal for our IVD and industry customers
looking to increase operational efficiencies while reducing their
overall costs. We remain committed to bringing innovation and
quality products to molecular assay development.”
Florent Chang-Pi-Hin, PhD, Senior Director of
Research and Development added, “We have seen a significant
increase in demand for our Lyo-Ready mixes, however not all our
customers have the expertise in house to do lyophilization.
Following increasing customer demands, we have developed the
Air-Dryable qPCR Mix as an easier and economic alternative that
still provides the high accuracy expected of our qPCR products. The
incorporation of magnesium in this optimized formulation is a great
achievement and will enable our customers to simplify and speed up
their assay development and workflow.”
For complete information, please visit
meridianlifescience.com/molecular-dx-reagents.
About Meridian Bioscience,
Inc.
Meridian is a fully integrated life science
company that develops, manufactures, markets and distributes a
broad range of innovative diagnostic products. We are dedicated to
developing and delivering better solutions that give answers with
speed, accuracy and simplicity that are redefining the
possibilities of life from discovery to diagnosis. Through
discovery and development, we provide critical life science raw
materials used in immunological and molecular tests for human,
animal, plant, and environmental applications. Through diagnosis,
we provide diagnostic solutions in areas including gastrointestinal
and upper respiratory infections and blood lead level testing. We
build relationships and provide solutions to hospitals, reference
laboratories, research centers, veterinary testing centers,
physician offices, diagnostics manufacturers, and biotech companies
in more than 70 countries around the world.
Meridian’s shares are traded on the NASDAQ
Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Meridian Contact:Charlie
WoodVice President – Investor RelationsMeridian Bioscience,
Inc.Phone: +1 513.271.3700Email:
mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Oct 2024 to Nov 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Nov 2023 to Nov 2024